Table 3.

Comparison of clinical prediction scores for severe ADAMTS13 deficiency

PLASMIC scoreFrench score, pointsBentley score, points
Component of score    
 Platelet count <30 × 109/L: 1 point ≤30 × 109/L: 1 point >35 × 109/L:−30 points  
 Creatinine level <2 mg/dL: 1 point ≤2.26 mg/dL: 1 point >2 mg/dL:−11.5 points  
 Parameters of hemolysis Reticulocyte count >2.5%: 1 point — Reticulocyte: >3% +21 points  
Indirect bilirubin >1.5 mg/dL:+20.5 points  
Haptoglobin undetectable: 1 point   
Indirect bilirubin >2 mg/dL: 1 point   
 Associated conditions No active cancer: 1 point — —  
No history of solid-organ or hematopoietic stem cell transplant: 1 point  
 MCV <90 fL: 1 point — —  
 INR <1.5: 1 point — —  
 ANA — Positive: 1 point —  
d-dimer — — >4 mcg/mL:−10 points  
Interpretation    
 Risk category, total score    
 Low 0-4 <20 
 Intermediate 20-30 
 High 6-7 2-3 >30 
PLASMIC scoreFrench score, pointsBentley score, points
Component of score    
 Platelet count <30 × 109/L: 1 point ≤30 × 109/L: 1 point >35 × 109/L:−30 points  
 Creatinine level <2 mg/dL: 1 point ≤2.26 mg/dL: 1 point >2 mg/dL:−11.5 points  
 Parameters of hemolysis Reticulocyte count >2.5%: 1 point — Reticulocyte: >3% +21 points  
Indirect bilirubin >1.5 mg/dL:+20.5 points  
Haptoglobin undetectable: 1 point   
Indirect bilirubin >2 mg/dL: 1 point   
 Associated conditions No active cancer: 1 point — —  
No history of solid-organ or hematopoietic stem cell transplant: 1 point  
 MCV <90 fL: 1 point — —  
 INR <1.5: 1 point — —  
 ANA — Positive: 1 point —  
d-dimer — — >4 mcg/mL:−10 points  
Interpretation    
 Risk category, total score    
 Low 0-4 <20 
 Intermediate 20-30 
 High 6-7 2-3 >30 

or Create an Account

Close Modal
Close Modal